Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple kinases refers to a broad group of enzymes that catalyze the transfer of phosphate groups from high-energy donor molecules (like ATP) to specific substrates, typically proteins. This process, known as phosphorylation, is fundamental in regulating cellular activities such as signal transduction, cell cycle progression, metabolism, and apoptosis. Dysregulation of kinase activity is implicated in many diseases—most notably cancer—due to their roles controlling cell proliferation and survival. Drugs targeting multiple kinases ("multikinase inhibitors") have been developed for complex diseases like cancer where several signaling pathways are dysregulated at once.
Inhibition of multiple kinase enzymes, blocking several signal transduction cascades simultaneously.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple kinases.